Patrick Aebischer News Today

- Timeline, a consumer health biotech company at the forefront of developing innovative solutions for healthy aging and longevity, today announces that it ...

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Timeline a consumer health biotech company at the forefront of developing innovative solutions for healthy aging and longevity today announces that it raised CHF 56M USD 66M in an oversubscribed Series D financing round.

L'Oréal's venture capital fund BOLD has just invested in Timeline, a Swiss biotech that specialises in longevity in the beauty and health sectors, as the focus on longevity grows in the beauty industry.

L'Oréal has taken a minority stake in Swiss longevity biotech company Timeline.

Through science diplomacy, Bern wants to make Geneva a centre of modern governance. GESDA embodies this ambition, but has yet to prove itself.

Urolithin A, a metabolite of ellagitannins in pomegranates, boosts immune cells' ability to combat tumors by inducing a ...

Urolithin A, a metabolite of ellagitannins in pomegranates, boosts immune cells' ability to combat tumors by inducing a ...

The quest to slow down ageing — and have healthier and longer lives — is ongoing. And it’s not just about living to 120.

“This deal is further validation of our strategy to invest in company creation in Europe," said Patrick Aebischer, Senior Partner at +ND Capital.